PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company provides…
USD63.49+0.21%vs prev. close
Performance
1W
-3.52%
1M
+5.74%
3M
-11.96%
1Y
-15.46%
YTD
-16.59%
Valuation
P/E
—
EPS TTM
-1.47
Dividend yield
—
Size and risk
Market cap
$5.3B
Beta
0.51
Price history
PTCT price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
PTC Therapeutics
PTCT
Biotechnology
Mkt cap (USD bn)
5.3
P/E
—
Div yld
—
1W
-3.5%
1M
+5.7%
3M
-12.0%
6M
-12.9%
1Y
-15.5%
YTD
-16.6%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
PTC Therapeutics
PTCT
Biotechnology
5.3
—
—
-3.5%
+5.7%
-12.0%
-12.9%
-15.5%
-16.6%
Subscribe to Equity Analytics to compare PTCT with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.